Articles by Suzan Wetzels in JoVE
应用流式细胞仪对人体脂肪组织免疫细胞的表征 Suzan Wetzels*1,2,3, Mitchell Bijnen*1,2, Erwin Wijnands2,4, Erik A.L. Biessen2,4, Casper G. Schalkwijk1,2, Kristiaan Wouters1,2 1Department of Internal Medicine, MUMC, 2CARIM, MUMC, 3Department of Immunology and Biochemistry, Biomedical Research Institute, Hasselt University, 4Department of Pathology, MUMC 本文介绍了一种用流式细胞仪从脂肪组织中分离免疫细胞来分析脂肪组织免疫细胞含量的方法和后续分析。
Other articles by Suzan Wetzels on PubMed
Circulating Classical Monocytes Are Associated with CD11cmacrophages in Human Visceral Adipose Tissue Scientific Reports. Feb, 2017 | Pubmed ID: 28198418 Immune cell accumulation in adipose tissue (AT) is associated with the development of AT inflammation, resulting in metabolic dysfunction. Circulating immune cell patterns may reflect immune cell accumulation in expanding AT. However, data linking human leukocytes in blood and AT is lacking. We investigated whether blood immune cell populations are associated with their counterparts in subcutaneous (scAT) or visceral AT (vAT). Flow cytometry was performed on blood, scAT and vAT from 16 lean and 29 obese men. Circulating natural killer (NK)-cells, classical monocytes and nonclassical monocytes were higher in obese individuals. vAT, but not scAT, of obese individuals contained more inflammatory CD11c"M1" macrophages and NK cells compared to lean individuals. Blood classical monocytes were associated with CD11cmacrophages in vAT but not scAT. This association was unrelated to expression of the adhesion molecules CD11b and CD11c or of the chemokine receptor CX3CR1 on these monocytes. Other AT immune cells were not associated with their respective counterparts in blood. Finally, CD11cmacrophages and CD4T-cells in vAT were associated with their counterparts in scAT. In conclusion, blood classical monocytes reflect CD11cmacrophages in vAT.
Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis International Journal of Molecular Sciences. Feb, 2017 | Pubmed ID: 28212304 Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). The activation of inflammatory cells is crucial for the development of MS and is shown to induce intracellular glycolytic metabolism in pro-inflammatory microglia and macrophages, as well as CNS-resident astrocytes. Advanced glycation endproducts (AGEs) are stable endproducts formed by a reaction of the dicarbonyl compounds methylglyoxal (MGO) and glyoxal (GO) with amino acids in proteins, during glycolysis. This suggests that, in MS, MGO-derived AGEs are formed in glycolysis-driven cells. MGO and MGO-derived AGEs can further activate inflammatory cells by binding to the receptor for advanced glycation endproducts (RAGE). Recent studies have revealed that AGEs are increased in the plasma and brain of MS patients. Therefore, AGEs might contribute to the inflammatory status in MS. Moreover, the main detoxification system of dicarbonyl compounds, the glyoxalase system, seems to be affected in MS patients, which may contribute to high MGO-derived AGE levels. Altogether, evidence is emerging for a contributing role of AGEs in the pathology of MS. In this review, we provide an overview of the current knowledge on the involvement of AGEs in MS.